{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:13:39Z","timestamp":1793654019376,"version":"4.5.1"},"reference-count":183,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangdong Provincial Innovation Team Program","award":["2025A04J5491"],"award-info":[{"award-number":["2025A04J5491"]}]},{"name":"R&D Program of Guangzhou National Laboratory","award":["SRPG22-017"],"award-info":[{"award-number":["SRPG22-017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"DOI":"10.1007\/s10555-026-10368-5","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T06:19:48Z","timestamp":1787379588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Epithelial\u2013mesenchymal transition in carcinoma: navigating phenotypic states to target resistance and metastasis"],"prefix":"10.1007","volume":"45","author":[{"given":"Xuecong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Paul","family":"Thiery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"issue":"6","key":"10368_CR1","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri, R., & Weinberg, R. A. (2009). The basics of epithelial-mesenchymal transition. Journal of Clinical Investigation, 119(6), 1420\u20131428. https:\/\/doi.org\/10.1172\/JCI39104","journal-title":"Journal of Clinical Investigation"},{"key":"10368_CR2","doi-asserted-by":"publisher","DOI":"10.1242\/dev.200128","author":"JP Thiery","year":"2024","unstructured":"Thiery, J. P., Sheng, G., Shu, X., & Runyan, R. (2024). How studies in developmental epithelial-mesenchymal transition and mesenchymal-epithelial transition inspired new research paradigms in biomedicine. Development. https:\/\/doi.org\/10.1242\/dev.200128","journal-title":"Development"},{"issue":"20","key":"10368_CR3","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1016\/j.cell.2025.08.033","volume":"188","author":"CX Zhang","year":"2025","unstructured":"Zhang, C. X., Huang, R. Y., Sheng, G., & Thiery, J. P. (2025). Epithelial-mesenchymal transition. Cell, 188(20), 5436\u20135486. https:\/\/doi.org\/10.1016\/j.cell.2025.08.033","journal-title":"Cell"},{"issue":"11","key":"10368_CR4","doi-asserted-by":"publisher","first-page":"e915","DOI":"10.1038\/cddis.2013.442","volume":"4","author":"RY Huang","year":"2013","unstructured":"Huang, R. Y., Wong, M. K., Tan, T. Z., Kuay, K. T., Ng, A. H., Chung, V. Y., et al. (2013). An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). Cell Death & Disease, 4(11), e915. https:\/\/doi.org\/10.1038\/cddis.2013.442","journal-title":"Cell Death & Disease"},{"issue":"19","key":"10368_CR5","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1242\/dev.071209","volume":"139","author":"J Lim","year":"2012","unstructured":"Lim, J., & Thiery, J. P. (2012). Epithelial-mesenchymal transitions: Insights from development. Development, 139(19), 3471\u20133486. https:\/\/doi.org\/10.1242\/dev.071209","journal-title":"Development"},{"issue":"6","key":"10368_CR6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery, J. P. (2002). Epithelial-mesenchymal transitions in tumor progression. Nature Reviews Cancer, 2(6), 442\u2013454. https:\/\/doi.org\/10.1038\/nrc822","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"10368_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto, M. A., Huang, R. Y., Jackson, R. A., & Thiery, J. P. (2016). Emt: 2016. Cell, 166(1), 21\u201345. https:\/\/doi.org\/10.1016\/j.cell.2016.06.028","journal-title":"Cell"},{"issue":"6","key":"10368_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang, J., Antin, P., Berx, G., Blanpain, C., Brabletz, T., Bronner, M., et al. (2020). Guidelines and definitions for research on epithelial-mesenchymal transition. Nature Reviews Molecular Cell Biology, 21(6), 341\u2013352. https:\/\/doi.org\/10.1038\/s41580-020-0237-9","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"3","key":"10368_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko, I., & Blanpain, C. (2019). EMT transition states during tumor progression and metastasis. Trends in Cell Biology, 29(3), 212\u2013226. https:\/\/doi.org\/10.1016\/j.tcb.2018.12.001","journal-title":"Trends in Cell Biology"},{"issue":"7973","key":"10368_CR10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-023-06372-2","volume":"620","author":"J Lengrand","year":"2023","unstructured":"Lengrand, J., Pastushenko, I., Vanuytven, S., Song, Y., Venet, D., Sarate, R. M., et al. (2023). Pharmacological targeting of netrin-1 inhibits EMT in cancer. Nature, 620(7973), 402\u2013408. https:\/\/doi.org\/10.1038\/s41586-023-06372-2","journal-title":"Nature"},{"issue":"1","key":"10368_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13058-024-01888-5","volume":"26","author":"HC Lien","year":"2024","unstructured":"Lien, H. C., Yu, H. C., Yu, W. H., Lin, S. F., Chen, T. W., Chen, I. C., et al. (2024). Characteristics and transcriptional regulators of spontaneous epithelial-mesenchymal transition in genetically unperturbed patient-derived non-spindled breast carcinoma. Breast Cancer Research, 26(1), 130. https:\/\/doi.org\/10.1186\/s13058-024-01888-5","journal-title":"Breast Cancer Research"},{"key":"10368_CR12","doi-asserted-by":"publisher","first-page":"807324","DOI":"10.3389\/fmolb.2022.807324","volume":"9","author":"SA Vilchez Mercedes","year":"2022","unstructured":"Vilchez Mercedes, S. A., Bocci, F., Ahmed, M., Eder, I., Zhu, N., Levine, H., et al. (2022). Nrf2 modulates the hybrid epithelial\/mesenchymal phenotype and notch signaling during collective cancer migration. Frontiers in Molecular Biosciences, 9, 807324. https:\/\/doi.org\/10.3389\/fmolb.2022.807324","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"10","key":"10368_CR13","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.tcb.2020.07.003","volume":"30","author":"B Bakir","year":"2020","unstructured":"Bakir, B., Chiarella, A. M., Pitarresi, J. R., & Rustgi, A. K. (2020). EMT, MET, plasticity, and tumor metastasis. Trends in Cell Biology, 30(10), 764\u2013776. https:\/\/doi.org\/10.1016\/j.tcb.2020.07.003","journal-title":"Trends in Cell Biology"},{"issue":"18","key":"10368_CR14","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108647","volume":"40","author":"S Brabletz","year":"2021","unstructured":"Brabletz, S., Schuhwerk, H., Brabletz, T., & Stemmler, M. P. (2021). Dynamic EMT: A multi-tool for tumor progression. EMBO Journal, 40(18), Article e108647. https:\/\/doi.org\/10.15252\/embj.2021108647","journal-title":"EMBO Journal"},{"key":"10368_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1146\/annurev-pathmechdis-051222-122423","volume":"19","author":"R Fontana","year":"2024","unstructured":"Fontana, R., Mestre-Farrera, A., & Yang, J. (2024). Update on epithelial-mesenchymal plasticity in cancer progression. Annual Review of Pathology: Mechanisms of Disease, 19, 133\u2013156. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-051222-122423","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"issue":"10","key":"10368_CR16","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1038\/s41588-024-01920-6","volume":"56","author":"JS Schiffman","year":"2024","unstructured":"Schiffman, J. S., D\u2019Avino, A. R., Prieto, T., Pang, Y., Fan, Y., Rajagopalan, S., et al. (2024). Defining heritability, plasticity, and transition dynamics of cellular phenotypes in somatic evolution. Nature Genetics, 56(10), 2174\u20132184. https:\/\/doi.org\/10.1038\/s41588-024-01920-6","journal-title":"Nature Genetics"},{"issue":"23","key":"10368_CR17","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1158\/0008-5472.CAN-21-4012","volume":"82","author":"GY Ho","year":"2022","unstructured":"Ho, G. Y., Kyran, E. L., Bedo, J., Wakefield, M. J., Ennis, D. P., Mirza, H. B., et al. (2022). Epithelial-to-mesenchymal transition supports ovarian carcinosarcoma tumorigenesis and confers sensitivity to microtubule targeting with eribulin. Cancer Research, 82(23), 4457\u20134473. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-4012","journal-title":"Cancer Research"},{"issue":"21","key":"10368_CR18","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202401991R","volume":"38","author":"MS Gopinatha Pillai","year":"2024","unstructured":"Gopinatha Pillai, M. S., Shaw, P., Dey Bhowmik, A., Bhattacharya, R., Rao, G., & Dhar Dwivedi, S. K. (2024). Uterine carcinosarcoma: Unraveling the role of epithelial-to-mesenchymal transition in progression and therapeutic potential. FASEB Journal, 38(21), Article e70132. https:\/\/doi.org\/10.1096\/fj.202401991R","journal-title":"FASEB Journal"},{"issue":"8104","key":"10368_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41586-025-09985-x","volume":"651","author":"JE Chan","year":"2026","unstructured":"Chan, J. E., Pan, C. H., Rub, J., Guzman, G., Krause, K., Brown, E., et al. (2026). Critical role for a high-plasticity cell state in lung cancer. Nature, 651(8104), 231\u2013241. https:\/\/doi.org\/10.1038\/s41586-025-09985-x","journal-title":"Nature"},{"key":"10368_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1146\/annurev-pathmechdis-031521-023557","volume":"18","author":"A Yamamoto","year":"2023","unstructured":"Yamamoto, A., Doak, A. E., & Cheung, K. J. (2023). Orchestration of collective migration and metastasis by tumor cell clusters. Annual Review of Pathology, 18, 231\u2013256. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-031521-023557","journal-title":"Annual Review of Pathology"},{"issue":"3","key":"10368_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.tcb.2021.10.004","volume":"32","author":"V Graziani","year":"2022","unstructured":"Graziani, V., Rodriguez-Hernandez, I., Maiques, O., & Sanz-Moreno, V. (2022). The amoeboid state as part of the epithelial-to-mesenchymal transition programme. Trends in Cell Biology, 32(3), 228\u2013242. https:\/\/doi.org\/10.1016\/j.tcb.2021.10.004","journal-title":"Trends in Cell Biology"},{"issue":"5","key":"10368_CR22","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.tcb.2022.09.009","volume":"33","author":"M Parlani","year":"2023","unstructured":"Parlani, M., Jorgez, C., & Friedl, P. (2023). Plasticity of cancer invasion and energy metabolism. Trends in Cell Biology, 33(5), 388\u2013402. https:\/\/doi.org\/10.1016\/j.tcb.2022.09.009","journal-title":"Trends in Cell Biology"},{"issue":"23","key":"10368_CR23","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1016\/j.devcel.2021.11.006","volume":"56","author":"F Luond","year":"2021","unstructured":"Luond, F., Sugiyama, N., Bill, R., Bornes, L., Hager, C., Tang, F., et al. (2021). Distinct contributions of partial and full EMT to breast cancer malignancy. Developmental Cell, 56(23), 3203-3221 e3211. https:\/\/doi.org\/10.1016\/j.devcel.2021.11.006","journal-title":"Developmental Cell"},{"issue":"1","key":"10368_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.devcel.2022.12.005","volume":"58","author":"PY Hwang","year":"2023","unstructured":"Hwang, P. Y., Mathur, J., Cao, Y., Almeida, J., Ye, J., Morikis, V., et al. (2023). A Cdh3-beta-catenin-laminin signaling axis in a subset of breast tumor leader cells control leader cell polarization and directional collective migration. Developmental Cell, 58(1), 34-50 e39. https:\/\/doi.org\/10.1016\/j.devcel.2022.12.005","journal-title":"Developmental Cell"},{"issue":"42","key":"10368_CR25","doi-asserted-by":"publisher","first-page":"eadi0244","DOI":"10.1126\/sciadv.adi0244","volume":"9","author":"R Samain","year":"2023","unstructured":"Samain, R., Maiques, O., Monger, J., Lam, H., Candido, J., George, S., et al. (2023). CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells. Science Advances, 9(42), eadi0244. https:\/\/doi.org\/10.1126\/sciadv.adi0244","journal-title":"Science Advances"},{"issue":"22","key":"10368_CR26","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1016\/j.devcel.2024.06.023","volume":"59","author":"JM Garcia-Arcos","year":"2024","unstructured":"Garcia-Arcos, J. M., Ziegler, J., Grigolon, S., Reymond, L., Shajepal, G., Cattin, C. J., et al. (2024). Rigidity percolation and active advection synergize in the actomyosin cortex to drive amoeboid cell motility. Developmental Cell, 59(22), 2990-3007 e2997. https:\/\/doi.org\/10.1016\/j.devcel.2024.06.023","journal-title":"Developmental Cell"},{"issue":"7952","key":"10368_CR27","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41586-023-05758-6","volume":"615","author":"AD Weems","year":"2023","unstructured":"Weems, A. D., Welf, E. S., Driscoll, M. K., Zhou, F. Y., Mazloom-Farsibaf, H., Chang, B. J., et al. (2023). Blebs promote cell survival by assembling oncogenic signalling hubs. Nature, 615(7952), 517\u2013525. https:\/\/doi.org\/10.1038\/s41586-023-05758-6","journal-title":"Nature"},{"issue":"39","key":"10368_CR28","doi-asserted-by":"publisher","first-page":"eabp8416","DOI":"10.1126\/sciadv.abp8416","volume":"8","author":"DL Pages","year":"2022","unstructured":"Pages, D. L., Dornier, E., de Seze, J., Gontran, E., Maitra, A., Maciejewski, A., et al. (2022). Cell clusters adopt a collective amoeboid mode of migration in confined nonadhesive environments. Science Advances, 8(39), eabp8416. https:\/\/doi.org\/10.1126\/sciadv.abp8416","journal-title":"Science Advances"},{"issue":"5","key":"10368_CR29","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1053\/j.gastro.2020.12.077","volume":"160","author":"M Liu","year":"2021","unstructured":"Liu, M., Zhang, Y., Yang, J., Zhan, H., Zhou, Z., Jiang, Y., et al. (2021). Zinc-dependent regulation of ZEB1 and YAP1 coactivation promotes epithelial-mesenchymal transition plasticity and metastasis in pancreatic cancer. Gastroenterology, 160(5), 1771-1783 e1771. https:\/\/doi.org\/10.1053\/j.gastro.2020.12.077","journal-title":"Gastroenterology"},{"issue":"867","key":"10368_CR30","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.1126\/scisignal.ado6057","volume":"17","author":"EN Arner","year":"2024","unstructured":"Arner, E. N., Alzhanova, D., Westcott, J. M., Hinz, S., Tiron, C. E., Blo, M., et al. (2024). AXL-TBK1 driven AKT3 activation promotes metastasis. Science Signaling, 17(867), 6057. https:\/\/doi.org\/10.1126\/scisignal.ado6057","journal-title":"Science Signaling"},{"issue":"23","key":"10368_CR31","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.1158\/0008-5472.CAN-21-1538","volume":"81","author":"S Liang","year":"2021","unstructured":"Liang, S., Guo, H., Ma, K., Li, X., Wu, D., Wang, Y., et al. (2021). A PLCB1-PI3K-AKT signaling axis activates EMT to promote cholangiocarcinoma progression. Cancer Research, 81(23), 5889\u20135903. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-1538","journal-title":"Cancer Research"},{"issue":"1","key":"10368_CR32","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41467-025-56299-7","volume":"16","author":"O Maiques","year":"2025","unstructured":"Maiques, O., Sallan, M. C., Laddach, R., Pandya, P., Varela, A., Crosas-Molist, E., et al. (2025). Matrix mechano-sensing at the invasive front induces a cytoskeletal and transcriptional memory supporting metastasis. Nature Communications, 16(1), 1394. https:\/\/doi.org\/10.1038\/s41467-025-56299-7","journal-title":"Nature Communications"},{"key":"10368_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba2894","author":"AJ Lomakin","year":"2020","unstructured":"Lomakin, A. J., Cattin, C. J., Cuvelier, D., Alraies, Z., Molina, M., Nader, G. P. F., et al. (2020). The nucleus acts as a ruler tailoring cell responses to spatial constraints. Science. https:\/\/doi.org\/10.1126\/science.aba2894","journal-title":"Science"},{"issue":"6304","key":"10368_CR34","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1126\/science.aaf7119","volume":"353","author":"R Sunyer","year":"2016","unstructured":"Sunyer, R., Conte, V., Escribano, J., Elosegui-Artola, A., Labernadie, A., Valon, L., et al. (2016). Collective cell durotaxis emerges from long-range intercellular force transmission. Science, 353(6304), 1157\u20131161. https:\/\/doi.org\/10.1126\/science.aaf7119","journal-title":"Science"},{"issue":"12","key":"10368_CR35","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nrm.2017.87","volume":"18","author":"T Panciera","year":"2017","unstructured":"Panciera, T., Azzolin, L., Cordenonsi, M., & Piccolo, S. (2017). Mechanobiology of YAP and TAZ in physiology and disease. Nature Reviews Molecular Cell Biology, 18(12), 758\u2013770. https:\/\/doi.org\/10.1038\/nrm.2017.87","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"7730","key":"10368_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-018-0658-1","volume":"563","author":"L Chang","year":"2018","unstructured":"Chang, L., Azzolin, L., Di Biagio, D., Zanconato, F., Battilana, G., Lucon Xiccato, R., et al. (2018). The SWI\/SNF complex is a mechanoregulated inhibitor of YAP and TAZ. Nature, 563(7730), 265\u2013269. https:\/\/doi.org\/10.1038\/s41586-018-0658-1","journal-title":"Nature"},{"issue":"8","key":"10368_CR37","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41556-018-0138-8","volume":"20","author":"EE Er","year":"2018","unstructured":"Er, E. E., Valiente, M., Ganesh, K., Zou, Y., Agrawal, S., Hu, J., et al. (2018). Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization. Nature Cell Biology, 20(8), 966\u2013978. https:\/\/doi.org\/10.1038\/s41556-018-0138-8","journal-title":"Nature Cell Biology"},{"issue":"3","key":"10368_CR38","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccell.2019.01.007","volume":"35","author":"J Cooper","year":"2019","unstructured":"Cooper, J., & Giancotti, F. G. (2019). Integrin signaling in cancer: Mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance. Cancer Cell, 35(3), 347\u2013367. https:\/\/doi.org\/10.1016\/j.ccell.2019.01.007","journal-title":"Cancer Cell"},{"issue":"1","key":"10368_CR39","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.1038\/s41467-021-26839-y","volume":"12","author":"S Marco","year":"2021","unstructured":"Marco, S., Neilson, M., Moore, M., Perez-Garcia, A., Hall, H., Mitchell, L., et al. (2021). Nuclear-capture of endosomes depletes nuclear G-actin to promote SRF\/MRTF activation and cancer cell invasion. Nature Communications, 12(1), 6829. https:\/\/doi.org\/10.1038\/s41467-021-26839-y","journal-title":"Nature Communications"},{"issue":"1","key":"10368_CR40","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.1038\/s41467-024-49230-z","volume":"15","author":"AA Khalil","year":"2024","unstructured":"Khalil, A. A., Smits, D., Haughton, P. D., Koorman, T., Jansen, K. A., Verhagen, M. P., et al. (2024). A YAP-centered mechanotransduction loop drives collective breast cancer cell invasion. Nature Communications, 15(1), 4866. https:\/\/doi.org\/10.1038\/s41467-024-49230-z","journal-title":"Nature Communications"},{"issue":"2","key":"10368_CR41","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre, A., & Weinberg, R. A. (2019). New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nature Reviews Molecular Cell Biology, 20(2), 69\u201384. https:\/\/doi.org\/10.1038\/s41580-018-0080-4","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"9","key":"10368_CR42","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41576-023-00601-0","volume":"24","author":"J Haerinck","year":"2023","unstructured":"Haerinck, J., Goossens, S., & Berx, G. (2023). The epithelial-mesenchymal plasticity landscape: Principles of design and mechanisms of regulation. Nature Reviews Genetics, 24(9), 590\u2013609. https:\/\/doi.org\/10.1038\/s41576-023-00601-0","journal-title":"Nature Reviews Genetics"},{"issue":"4","key":"10368_CR43","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41556-022-00877-0","volume":"24","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y., Donaher, J. L., Das, S., Li, X., Reinhardt, F., Krall, J. A., et al. (2022). Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis. Nature Cell Biology, 24(4), 554\u2013564. https:\/\/doi.org\/10.1038\/s41556-022-00877-0","journal-title":"Nature Cell Biology"},{"issue":"7791","key":"10368_CR44","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-019-1897-5","volume":"577","author":"J Su","year":"2020","unstructured":"Su, J., Morgani, S. M., David, C. J., Wang, Q., Er, E. E., Huang, Y. H., et al. (2020). TGF-beta orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1. Nature, 577(7791), 566\u2013571. https:\/\/doi.org\/10.1038\/s41586-019-1897-5","journal-title":"Nature"},{"issue":"22","key":"10368_CR45","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1016\/j.cell.2024.08.014","volume":"187","author":"JH Lee","year":"2024","unstructured":"Lee, J. H., Sanchez-Rivera, F. J., He, L., Basnet, H., Chen, F. X., Spina, E., et al. (2024). TGF-beta and RAS jointly unmask primed enhancers to drive metastasis. Cell, 187(22), 6182-6199 e6129. https:\/\/doi.org\/10.1016\/j.cell.2024.08.014","journal-title":"Cell"},{"issue":"9","key":"10368_CR46","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/j.ymthe.2020.05.026","volume":"28","author":"Y Qiao","year":"2020","unstructured":"Qiao, Y., Wang, Z., Tan, F., Chen, J., Lin, J., Yang, J., et al. (2020). Enhancer reprogramming within pre-existing topologically associated domains promotes TGF-beta-induced EMT and cancer metastasis. Molecular Therapy, 28(9), 2083\u20132095. https:\/\/doi.org\/10.1016\/j.ymthe.2020.05.026","journal-title":"Molecular Therapy"},{"issue":"1","key":"10368_CR47","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41556-022-01045-0","volume":"25","author":"J Cui","year":"2023","unstructured":"Cui, J., Zhang, C., Lee, J. E., Bartholdy, B. A., Yang, D., Liu, Y., et al. (2023). MLL3 loss drives metastasis by promoting a hybrid epithelial-mesenchymal transition state. Nature Cell Biology, 25(1), 145\u2013158. https:\/\/doi.org\/10.1038\/s41556-022-01045-0","journal-title":"Nature Cell Biology"},{"issue":"21","key":"10368_CR48","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1038\/s41388-023-02687-6","volume":"42","author":"H Gao","year":"2023","unstructured":"Gao, H., Wei, H., Yang, Y., Li, H., Liang, J., Ye, J., et al. (2023). Phase separation of DDX21 promotes colorectal cancer metastasis via MCM5-dependent EMT pathway. Oncogene, 42(21), 1704\u20131715. https:\/\/doi.org\/10.1038\/s41388-023-02687-6","journal-title":"Oncogene"},{"issue":"1","key":"10368_CR49","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang, Y., Hong, W., & Wei, X. (2022). The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. Journal of Hematology & Oncology, 15(1), 129. https:\/\/doi.org\/10.1186\/s13045-022-01347-8","journal-title":"Journal of Hematology & Oncology"},{"key":"10368_CR50","doi-asserted-by":"publisher","first-page":"102245","DOI":"10.1016\/j.ceb.2023.102245","volume":"85","author":"CA Horta","year":"2023","unstructured":"Horta, C. A., Doan, K., & Yang, J. (2023). Mechanotransduction pathways in regulating epithelial-mesenchymal plasticity. Current Opinion in Cell Biology, 85, 102245. https:\/\/doi.org\/10.1016\/j.ceb.2023.102245","journal-title":"Current Opinion in Cell Biology"},{"issue":"198","key":"10368_CR51","doi-asserted-by":"publisher","first-page":"20220627","DOI":"10.1098\/rsif.2022.0627","volume":"20","author":"P Jain","year":"2023","unstructured":"Jain, P., Corbo, S., Mohammad, K., Sahoo, S., Ranganathan, S., George, J. T., et al. (2023). Epigenetic memory acquired during long-term EMT induction governs the recovery to the epithelial state. Journal of the Royal Society, Interface, 20(198), 20220627. https:\/\/doi.org\/10.1098\/rsif.2022.0627","journal-title":"Journal of the Royal Society, Interface"},{"issue":"3","key":"10368_CR52","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1158\/0008-5472.CAN-09-1872","volume":"70","author":"P Papageorgis","year":"2010","unstructured":"Papageorgis, P., Lambert, A. W., Ozturk, S., Gao, F., Pan, H., Manne, U., et al. (2010). Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Research, 70(3), 968\u2013978. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1872","journal-title":"Cancer Research"},{"issue":"6","key":"10368_CR53","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.devcel.2018.05.027","volume":"45","author":"NM Aiello","year":"2018","unstructured":"Aiello, N. M., Maddipati, R., Norgard, R. J., Balli, D., Li, J., Yuan, S., et al. (2018). EMT subtype influences epithelial plasticity and mode of cell migration. Developmental Cell, 45(6), 681-695 e684. https:\/\/doi.org\/10.1016\/j.devcel.2018.05.027","journal-title":"Developmental Cell"},{"issue":"1","key":"10368_CR54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tcb.2020.09.010","volume":"31","author":"SC Baksh","year":"2021","unstructured":"Baksh, S. C., & Finley, L. W. S. (2021). Metabolic coordination of cell fate by alpha-ketoglutarate-dependent dioxygenases. Trends in Cell Biology, 31(1), 24\u201336. https:\/\/doi.org\/10.1016\/j.tcb.2020.09.010","journal-title":"Trends in Cell Biology"},{"issue":"6","key":"10368_CR55","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.7150\/ijbs.76756","volume":"19","author":"Q Ji","year":"2023","unstructured":"Ji, Q., Li, H., Cai, Z., Yuan, X., Pu, X., Huang, Y., et al. (2023). PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer. International Journal of Biological Sciences, 19(6), 1894\u20131909. https:\/\/doi.org\/10.7150\/ijbs.76756","journal-title":"International Journal of Biological Sciences"},{"issue":"9","key":"10368_CR56","doi-asserted-by":"publisher","first-page":"e20200388","DOI":"10.1084\/jem.20200388","volume":"217","author":"MV Recouvreux","year":"2020","unstructured":"Recouvreux, M. V., Moldenhauer, M. R., Galenkamp, K. M. O., Jung, M., James, B., Zhang, Y., et al. (2020). Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer. Journal of Experimental Medicine, 217(9), e20200388. https:\/\/doi.org\/10.1084\/jem.20200388","journal-title":"Journal of Experimental Medicine"},{"issue":"11","key":"10368_CR57","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1158\/0008-5472.CAN-23-2889","volume":"84","author":"S Wan","year":"2024","unstructured":"Wan, S., He, Q. Y., Yang, Y., Liu, F., Zhang, X., Guo, X., et al. (2024). SPARC stabilizes ApoE to induce cholesterol-dependent invasion and sorafenib resistance in hepatocellular carcinoma. Cancer Research, 84(11), 1872\u20131888. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-2889","journal-title":"Cancer Research"},{"issue":"5","key":"10368_CR58","doi-asserted-by":"publisher","first-page":"115627","DOI":"10.1016\/j.celrep.2025.115627","volume":"44","author":"JS Weissenrieder","year":"2025","unstructured":"Weissenrieder, J. S., Peura, J., Paudel, U., Bhalerao, N., Weinmann, N., Johnson, C., et al. (2025). Mitochondrial Ca(2+) controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticity. Cell Reports, 44(5), 115627. https:\/\/doi.org\/10.1016\/j.celrep.2025.115627","journal-title":"Cell Reports"},{"issue":"1","key":"10368_CR59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41419-023-05583-9","volume":"14","author":"P Konieczny","year":"2023","unstructured":"Konieczny, P., Adamus, T., Sulkowski, M., Skrzypek, K., & Majka, M. (2023). Impact of AMPK on cervical carcinoma progression and metastasis. Cell Death & Disease, 14(1), 43. https:\/\/doi.org\/10.1038\/s41419-023-05583-9","journal-title":"Cell Death & Disease"},{"issue":"19","key":"10368_CR60","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1111\/febs.14090","volume":"284","author":"M Sciacovelli","year":"2017","unstructured":"Sciacovelli, M., & Frezza, C. (2017). Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer. FEBS Journal, 284(19), 3132\u20133144. https:\/\/doi.org\/10.1111\/febs.14090","journal-title":"FEBS Journal"},{"key":"10368_CR61","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3389\/fonc.2020.00499","volume":"10","author":"I Georgakopoulos-Soares","year":"2020","unstructured":"Georgakopoulos-Soares, I., Chartoumpekis, D. V., Kyriazopoulou, V., & Zaravinos, A. (2020). EMT factors and metabolic pathways in cancer. Frontiers in Oncology, 10, 499. https:\/\/doi.org\/10.3389\/fonc.2020.00499","journal-title":"Frontiers in Oncology"},{"issue":"5930","key":"10368_CR62","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1126\/science.1164097","volume":"324","author":"KE Wellen","year":"2009","unstructured":"Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., & Thompson, C. B. (2009). ATP-citrate lyase links cellular metabolism to histone acetylation. Science, 324(5930), 1076\u20131080. https:\/\/doi.org\/10.1126\/science.1164097","journal-title":"Science"},{"issue":"2","key":"10368_CR63","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrm.2016.140","volume":"18","author":"BR Sabari","year":"2017","unstructured":"Sabari, B. R., Zhang, D., Allis, C. D., & Zhao, Y. (2017). Metabolic regulation of gene expression through histone acylations. Nature Reviews Molecular Cell Biology, 18(2), 90\u2013101. https:\/\/doi.org\/10.1038\/nrm.2016.140","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"1","key":"10368_CR64","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/nyas.12956","volume":"1363","author":"SJ Mentch","year":"2016","unstructured":"Mentch, S. J., & Locasale, J. W. (2016). One-carbon metabolism and epigenetics: Understanding the specificity. Annals of the New York Academy of Sciences, 1363(1), 91\u201398. https:\/\/doi.org\/10.1111\/nyas.12956","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"12","key":"10368_CR65","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/s41568-020-00303-3","volume":"20","author":"JA Losman","year":"2020","unstructured":"Losman, J. A., Koivunen, P., & Kaelin, W. G., Jr. (2020). 2-Oxoglutarate-dependent dioxygenases in cancer. Nature Reviews Cancer, 20(12), 710\u2013726. https:\/\/doi.org\/10.1038\/s41568-020-00303-3","journal-title":"Nature Reviews Cancer"},{"issue":"8","key":"10368_CR66","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tcb.2014.04.002","volume":"24","author":"S Imai","year":"2014","unstructured":"Imai, S., & Guarente, L. (2014). NAD+ and sirtuins in aging and disease. Trends in Cell Biology, 24(8), 464\u2013471. https:\/\/doi.org\/10.1016\/j.tcb.2014.04.002","journal-title":"Trends in Cell Biology"},{"issue":"12","key":"10368_CR67","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1101\/gad.191056.112","volume":"26","author":"M Xiao","year":"2012","unstructured":"Xiao, M., Yang, H., Xu, W., Ma, S., Lin, H., Zhu, H., et al. (2012). Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes & Development, 26(12), 1326\u20131338. https:\/\/doi.org\/10.1101\/gad.191056.112","journal-title":"Genes & Development"},{"issue":"7621","key":"10368_CR68","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature19353","volume":"537","author":"M Sciacovelli","year":"2016","unstructured":"Sciacovelli, M., Goncalves, E., Johnson, T. I., Zecchini, V. R., da Costa, A. S., Gaude, E., et al. (2016). Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition. Nature, 537(7621), 544\u2013547. https:\/\/doi.org\/10.1038\/nature19353","journal-title":"Nature"},{"issue":"7779","key":"10368_CR69","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang, D., Tang, Z., Huang, H., Zhou, G., Cui, C., Weng, Y., et al. (2019). Metabolic regulation of gene expression by histone lactylation. Nature, 574(7779), 575\u2013580. https:\/\/doi.org\/10.1038\/s41586-019-1678-1","journal-title":"Nature"},{"issue":"3","key":"10368_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113897","volume":"43","author":"FR Palma","year":"2024","unstructured":"Palma, F. R., Coelho, D. R., Pulakanti, K., Sakiyama, M. J., Huang, Y., Ogata, F. T., et al. (2024). Histone H3.1 is a chromatin-embedded redox sensor triggered by tumor cells developing adaptive phenotypic plasticity and multidrug resistance. Cell Reports, 43(3), Article 113897. https:\/\/doi.org\/10.1016\/j.celrep.2024.113897","journal-title":"Cell Reports"},{"issue":"9","key":"10368_CR71","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1158\/1541-7786.MCR-20-0962","volume":"19","author":"ST Karvelsson","year":"2021","unstructured":"Karvelsson, S. T., Sigurdsson, A., Seip, K., Grinde, M. T., Wang, Q., Johannsson, F., et al. (2021). EMT-derived alterations in glutamine metabolism sensitize mesenchymal breast cells to mTOR inhibition. Molecular Cancer Research, 19(9), 1546\u20131558. https:\/\/doi.org\/10.1158\/1541-7786.MCR-20-0962","journal-title":"Molecular Cancer Research"},{"issue":"12","key":"10368_CR72","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/s41416-022-01747-0","volume":"126","author":"Y Li","year":"2022","unstructured":"Li, Y., Liu, C., Zhang, X., Huang, X., Liang, S., Xing, F., et al. (2022). CCT5 induces epithelial-mesenchymal transition to promote gastric cancer lymph node metastasis by activating the Wnt\/beta-catenin signalling pathway. British Journal of Cancer, 126(12), 1684\u20131694. https:\/\/doi.org\/10.1038\/s41416-022-01747-0","journal-title":"British Journal of Cancer"},{"issue":"11","key":"10368_CR73","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.1073\/pnas.1918167117","volume":"117","author":"TY Na","year":"2020","unstructured":"Na, T. Y., Schecterson, L., Mendonsa, A. M., & Gumbiner, B. M. (2020). The functional activity of E-cadherin controls tumor cell metastasis at multiple steps. Proceedings of the National Academy of Sciences, 117(11), 5931\u20135937. https:\/\/doi.org\/10.1073\/pnas.1918167117","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"6","key":"10368_CR74","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1083\/jcb.200403043","volume":"167","author":"YS Chu","year":"2004","unstructured":"Chu, Y. S., Thomas, W. A., Eder, O., Pincet, F., Perez, E., Thiery, J. P., et al. (2004). Force measurements in E-cadherin-mediated cell doublets reveal rapid adhesion strengthened by actin cytoskeleton remodeling through Rac and Cdc42. Journal of Cell Biology, 167(6), 1183\u20131194. https:\/\/doi.org\/10.1083\/jcb.200403043","journal-title":"Journal of Cell Biology"},{"issue":"7702","key":"10368_CR75","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","volume":"556","author":"I Pastushenko","year":"2018","unstructured":"Pastushenko, I., Brisebarre, A., Sifrim, A., Fioramonti, M., Revenco, T., Boumahdi, S., et al. (2018). Identification of the tumour transition states occurring during EMT. Nature, 556(7702), 463\u2013468. https:\/\/doi.org\/10.1038\/s41586-018-0040-3","journal-title":"Nature"},{"key":"10368_CR76","doi-asserted-by":"publisher","DOI":"10.1088\/1478-3975\/ac482c","author":"AR Subbalakshmi","year":"2022","unstructured":"Subbalakshmi, A. R., Ashraf, B., & Jolly, M. K. (2022). Biophysical and biochemical attributes of hybrid epithelial\/mesenchymal phenotypes. Physical Biology. https:\/\/doi.org\/10.1088\/1478-3975\/ac482c","journal-title":"Physical Biology"},{"issue":"1","key":"10368_CR77","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","volume":"141","author":"SV Sharma","year":"2010","unstructured":"Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., et al. (2010). A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell, 141(1), 69\u201380. https:\/\/doi.org\/10.1016\/j.cell.2010.02.027","journal-title":"Cell"},{"issue":"4","key":"10368_CR78","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.cell.2020.10.027","volume":"183","author":"S Shen","year":"2020","unstructured":"Shen, S., Vagner, S., & Robert, C. (2020). Persistent cancer cells: The deadly survivors. Cell, 183(4), 860\u2013874. https:\/\/doi.org\/10.1016\/j.cell.2020.10.027","journal-title":"Cell"},{"issue":"2","key":"10368_CR79","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/1878-0261.13601","volume":"18","author":"M Russo","year":"2024","unstructured":"Russo, M. (2024). Genetic and non-genetic drug resistance: Darwin or Lamarck? Molecular Oncology, 18(2), 241\u2013244. https:\/\/doi.org\/10.1002\/1878-0261.13601","journal-title":"Molecular Oncology"},{"issue":"8","key":"10368_CR80","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/ng.2330","volume":"44","author":"Z Zhang","year":"2012","unstructured":"Zhang, Z., Lee, J. C., Lin, L., Olivas, V., Au, V., LaFramboise, T., et al. (2012). Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer. Nature Genetics, 44(8), 852\u2013860. https:\/\/doi.org\/10.1038\/ng.2330","journal-title":"Nature Genetics"},{"issue":"1","key":"10368_CR81","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41467-018-08074-0","volume":"10","author":"H Taniguchi","year":"2019","unstructured":"Taniguchi, H., Yamada, T., Wang, R., Tanimura, K., Adachi, Y., Nishiyama, A., et al. (2019). AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells. Nature Communications, 10(1), 259. https:\/\/doi.org\/10.1038\/s41467-018-08074-0","journal-title":"Nature Communications"},{"issue":"1","key":"10368_CR82","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ccell.2019.12.006","volume":"37","author":"KJ Kurppa","year":"2020","unstructured":"Kurppa, K. J., Liu, Y., To, C., Zhang, T., Fan, M., Vajdi, A., et al. (2020). Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway. Cancer Cell, 37(1), 104-122 e112. https:\/\/doi.org\/10.1016\/j.ccell.2019.12.006","journal-title":"Cancer Cell"},{"issue":"2","key":"10368_CR83","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ccell.2023.01.007","volume":"41","author":"MB Nilsson","year":"2023","unstructured":"Nilsson, M. B., Yang, Y., Heeke, S., Patel, S. A., Poteete, A., Udagawa, H., et al. (2023). CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance. Cancer Cell, 41(2), 340-355 e346. https:\/\/doi.org\/10.1016\/j.ccell.2023.01.007","journal-title":"Cancer Cell"},{"issue":"13","key":"10368_CR84","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1158\/0008-5472.CAN-13-3456","volume":"74","author":"D Raha","year":"2014","unstructured":"Raha, D., Wilson, T. R., Peng, J., Peterson, D., Yue, P., Evangelista, M., et al. (2014). The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation. Cancer Research, 74(13), 3579\u20133590. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-3456","journal-title":"Cancer Research"},{"issue":"6","key":"10368_CR85","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ccr.2013.05.003","volume":"23","author":"A Roesch","year":"2013","unstructured":"Roesch, A., Vultur, A., Bogeski, I., Wang, H., Zimmermann, K. M., Speicher, D., et al. (2013). Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. Cancer Cell, 23(6), 811\u2013825. https:\/\/doi.org\/10.1016\/j.ccr.2013.05.003","journal-title":"Cancer Cell"},{"issue":"4","key":"10368_CR86","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.cell.2018.06.025","volume":"174","author":"F Rambow","year":"2018","unstructured":"Rambow, F., Rogiers, A., Marin-Bejar, O., Aibar, S., Femel, J., Dewaele, M., et al. (2018). Toward minimal residual disease-directed therapy in melanoma. Cell, 174(4), 843-855 e819. https:\/\/doi.org\/10.1016\/j.cell.2018.06.025","journal-title":"Cell"},{"issue":"9","key":"10368_CR87","doi-asserted-by":"publisher","first-page":"dmm049566","DOI":"10.1242\/dmm.049566","volume":"15","author":"J Travnickova","year":"2022","unstructured":"Travnickova, J., Muise, S., Wojciechowska, S., Brombin, A., Zeng, Z., Young, A. I. J., et al. (2022). Fate mapping melanoma persister cells through regression and into recurrent disease in adult zebrafish. Disease Models & Mechanisms, 15(9), dmm049566. https:\/\/doi.org\/10.1242\/dmm.049566","journal-title":"Disease Models & Mechanisms"},{"issue":"2","key":"10368_CR88","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.stem.2016.11.003","volume":"20","author":"BB Liau","year":"2017","unstructured":"Liau, B. B., Sievers, C., Donohue, L. K., Gillespie, S. M., Flavahan, W. A., Miller, T. E., et al. (2017). Adaptive chromatin remodeling drives glioblastoma stem cell plasticity and drug tolerance. Cell Stem Cell, 20(2), 233-246 e237. https:\/\/doi.org\/10.1016\/j.stem.2016.11.003","journal-title":"Cell Stem Cell"},{"issue":"9","key":"10368_CR89","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s43018-022-00402-0","volume":"3","author":"A Alvarez-Varela","year":"2022","unstructured":"Alvarez-Varela, A., Novellasdemunt, L., Barriga, F. M., Hernando-Momblona, X., Canellas-Socias, A., Cano-Crespo, S., et al. (2022). Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy. Nature Cancer, 3(9), 1052\u20131070. https:\/\/doi.org\/10.1038\/s43018-022-00402-0","journal-title":"Nature Cancer"},{"issue":"1","key":"10368_CR90","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.cell.2020.11.018","volume":"184","author":"SK Rehman","year":"2021","unstructured":"Rehman, S. K., Haynes, J., Collignon, E., Brown, K. R., Wang, Y., Nixon, A. M. L., et al. (2021). Colorectal cancer cells enter a diapause-like DTP state to survive chemotherapy. Cell, 184(1), 226-242 e221. https:\/\/doi.org\/10.1016\/j.cell.2020.11.018","journal-title":"Cell"},{"issue":"488","key":"10368_CR91","doi-asserted-by":"publisher","first-page":"eaav936","DOI":"10.1126\/scitranslmed.aav0936","volume":"11","author":"GV Echeverria","year":"2019","unstructured":"Echeverria, G. V., Ge, Z., Seth, S., Zhang, X., Jeter-Jones, S., Zhou, X., et al. (2019). Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state. Science Translational Medicine, 11(488), eaav936. https:\/\/doi.org\/10.1126\/scitranslmed.aav0936","journal-title":"Science Translational Medicine"},{"issue":"4","key":"10368_CR92","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41588-022-01047-6","volume":"54","author":"J Marsolier","year":"2022","unstructured":"Marsolier, J., Prompsy, P., Durand, A., Lyne, A. M., Landragin, C., Trouchet, A., et al. (2022). H3K27me3 conditions chemotolerance in triple-negative breast cancer. Nature Genetics, 54(4), 459\u2013468. https:\/\/doi.org\/10.1038\/s41588-022-01047-6","journal-title":"Nature Genetics"},{"issue":"3","key":"10368_CR93","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nm.4040","volume":"22","author":"AN Hata","year":"2016","unstructured":"Hata, A. N., Niederst, M. J., Archibald, H. L., Gomez-Caraballo, M., Siddiqui, F. M., Mulvey, H. E., et al. (2016). Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition. Nature Medicine, 22(3), 262\u2013269. https:\/\/doi.org\/10.1038\/nm.4040","journal-title":"Nature Medicine"},{"issue":"6472","key":"10368_CR94","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1126\/science.aav4474","volume":"366","author":"M Russo","year":"2019","unstructured":"Russo, M., Crisafulli, G., Sogari, A., Reilly, N. M., Arena, S., Lamba, S., et al. (2019). Adaptive mutability of colorectal cancers in response to targeted therapies. Science, 366(6472), 1473\u20131480. https:\/\/doi.org\/10.1126\/science.aav4474","journal-title":"Science"},{"issue":"1","key":"10368_CR95","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s12967-023-04303-3","volume":"21","author":"Q Ping","year":"2023","unstructured":"Ping, Q., Wang, C., Cheng, X., Zhong, Y., Yan, R., Yang, M., et al. (2023). TGF-beta1 dominates stromal fibroblast-mediated EMT via the FAP\/VCAN axis in bladder cancer cells. Journal of Translational Medicine, 21(1), 475. https:\/\/doi.org\/10.1186\/s12967-023-04303-3","journal-title":"Journal of Translational Medicine"},{"issue":"5","key":"10368_CR96","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41419-022-04935-1","volume":"13","author":"H Xu","year":"2022","unstructured":"Xu, H., Zhao, J., Li, J., Zhu, Z., Cui, Z., Liu, R., et al. (2022). Cancer associated fibroblast-derived CCL5 promotes hepatocellular carcinoma metastasis through activating HIF1alpha\/ZEB1 axis. Cell Death & Disease, 13(5), 478. https:\/\/doi.org\/10.1038\/s41419-022-04935-1","journal-title":"Cell Death & Disease"},{"issue":"1","key":"10368_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02180-y","volume":"23","author":"X Zhou","year":"2024","unstructured":"Zhou, X., Han, J., Zuo, A., Ba, Y., Liu, S., Xu, H., et al. (2024). THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K\/AKT activation in colorectal cancer. Molecular Cancer, 23(1), Article 282. https:\/\/doi.org\/10.1186\/s12943-024-02180-y","journal-title":"Molecular Cancer"},{"issue":"1","key":"10368_CR98","doi-asserted-by":"publisher","first-page":"17412","DOI":"10.1038\/s41598-024-68109-z","volume":"14","author":"E Li","year":"2024","unstructured":"Li, E., Cheung, H. C. Z., & Ma, S. (2024). CTHRC1(+) fibroblasts and SPP1(+) macrophages synergistically contribute to pro-tumorigenic tumor microenvironment in pancreatic ductal adenocarcinoma. Science and Reports, 14(1), 17412. https:\/\/doi.org\/10.1038\/s41598-024-68109-z","journal-title":"Science and Reports"},{"issue":"1","key":"10368_CR99","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-024-02062-3","volume":"23","author":"DZ Guo","year":"2024","unstructured":"Guo, D. Z., Zhang, X., Zhang, S. Q., Zhang, S. Y., Zhang, X. Y., Yan, J. Y., et al. (2024). Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: Unraveling the pro-metastatic subtype and its interaction loop with fibroblasts. Molecular Cancer, 23(1), 157. https:\/\/doi.org\/10.1186\/s12943-024-02062-3","journal-title":"Molecular Cancer"},{"issue":"1","key":"10368_CR100","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12943-019-0976-4","volume":"18","author":"C Wei","year":"2019","unstructured":"Wei, C., Yang, C., Wang, S., Shi, D., Zhang, C., Lin, X., et al. (2019). Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Molecular Cancer, 18(1), 64. https:\/\/doi.org\/10.1186\/s12943-019-0976-4","journal-title":"Molecular Cancer"},{"issue":"1","key":"10368_CR101","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13046-024-02989-x","volume":"43","author":"Z Hu","year":"2024","unstructured":"Hu, Z., Sui, Q., Jin, X., Shan, G., Huang, Y., Yi, Y., et al. (2024). IL6-STAT3-C\/EBPbeta-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma. Journal of Experimental & Clinical Cancer Research, 43(1), 63. https:\/\/doi.org\/10.1186\/s13046-024-02989-x","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"7","key":"10368_CR102","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.7150\/ijbs.66854","volume":"18","author":"Z Bao","year":"2022","unstructured":"Bao, Z., Zeng, W., Zhang, D., Wang, L., Deng, X., Lai, J., et al. (2022). SNAIL induces EMT and lung metastasis of tumours secreting CXCL2 to promote the invasion of M2-type immunosuppressed macrophages in colorectal cancer. International Journal of Biological Sciences, 18(7), 2867\u20132881. https:\/\/doi.org\/10.7150\/ijbs.66854","journal-title":"International Journal of Biological Sciences"},{"issue":"1","key":"10368_CR103","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1038\/s41467-021-24009-8","volume":"12","author":"EA Pietila","year":"2021","unstructured":"Pietila, E. A., Gonzalez-Molina, J., Moyano-Galceran, L., Jamalzadeh, S., Zhang, K., Lehtinen, L., et al. (2021). Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance. Nature Communications, 12(1), 3904. https:\/\/doi.org\/10.1038\/s41467-021-24009-8","journal-title":"Nature Communications"},{"key":"10368_CR104","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jconrel.2022.11.006","volume":"352","author":"Y Yan","year":"2022","unstructured":"Yan, Y., Li, J., Yi, X., Liu, C., Zhou, Z., Huang, Y., et al. (2022). Peritumoral scaffold neutralizes tumor pH for chemotherapy sensitization and metastasis inhibition. Journal of Controlled Release, 352, 747\u2013758. https:\/\/doi.org\/10.1016\/j.jconrel.2022.11.006","journal-title":"Journal of Controlled Release"},{"key":"10368_CR105","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2021.4960","author":"T Zhu","year":"2021","unstructured":"Zhu, T., Zou, X., Yang, C., Li, L., Wang, B., Li, R., et al. (2021). Neutrophil extracellular traps promote gastric cancer metastasis by inducing epithelial\u2011mesenchymal transition. International Journal of Molecular Medicine. https:\/\/doi.org\/10.3892\/ijmm.2021.4960","journal-title":"International Journal of Molecular Medicine"},{"key":"10368_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217161","volume":"600","author":"M Lu","year":"2024","unstructured":"Lu, M., Gong, X., Zhang, Y. M., Guo, Y. W., Zhu, Y., Zeng, X. B., et al. (2024). Platelets promote primary hepatocellular carcinoma metastasis through TGF-beta1-mediated cancer cell autophagy. Cancer Letters, 600, Article 217161. https:\/\/doi.org\/10.1016\/j.canlet.2024.217161","journal-title":"Cancer Letters"},{"issue":"8084","key":"10368_CR107","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41586-025-09370-8","volume":"646","author":"EN Baruch","year":"2025","unstructured":"Baruch, E. N., Gleber-Netto, F. O., Nagarajan, P., Rao, X., Akhter, S., Eichwald, T., et al. (2025). Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy. Nature, 646(8084), 462\u2013473. https:\/\/doi.org\/10.1038\/s41586-025-09370-8","journal-title":"Nature"},{"issue":"1","key":"10368_CR108","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/s41467-025-56714-z","volume":"16","author":"W Jiang","year":"2025","unstructured":"Jiang, W., Guan, B., Sun, H., Mi, Y., Cai, S., Wan, R., et al. (2025). WNT11 Promotes immune evasion and resistance to anti-PD-1 therapy in liver metastasis. Nature Communications, 16(1), 1429. https:\/\/doi.org\/10.1038\/s41467-025-56714-z","journal-title":"Nature Communications"},{"issue":"8080","key":"10368_CR109","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41586-025-09278-3","volume":"645","author":"JM Adrover","year":"2025","unstructured":"Adrover, J. M., Han, X., Sun, L., Fujii, T., Sivetz, N., Dassler-Plenker, J., et al. (2025). Neutrophils drive vascular occlusion, tumour necrosis and metastasis. Nature, 645(8080), 484\u2013495. https:\/\/doi.org\/10.1038\/s41586-025-09278-3","journal-title":"Nature"},{"issue":"3","key":"10368_CR110","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ccell.2023.02.001","volume":"41","author":"JM Adrover","year":"2023","unstructured":"Adrover, J. M., McDowell, S. A. C., He, X. Y., Quail, D. F., & Egeblad, M. (2023). NETworking with cancer: The bidirectional interplay between cancer and neutrophil extracellular traps. Cancer Cell, 41(3), 505\u2013526. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.001","journal-title":"Cancer Cell"},{"issue":"1","key":"10368_CR111","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1152\/physrev.00062.2021","volume":"103","author":"M Herre","year":"2023","unstructured":"Herre, M., Cedervall, J., Mackman, N., & Olsson, A. K. (2023). Neutrophil extracellular traps in the pathology of cancer and other inflammatory diseases. Physiological Reviews, 103(1), 277\u2013312. https:\/\/doi.org\/10.1152\/physrev.00062.2021","journal-title":"Physiological Reviews"},{"issue":"1","key":"10368_CR112","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1080\/07853890.2023.2180155","volume":"55","author":"Z Yin","year":"2023","unstructured":"Yin, Z., & Wang, L. (2023). Endothelial-to-mesenchymal transition in tumour progression and its potential roles in tumour therapy. Annals of Medicine, 55(1), 1058\u20131069. https:\/\/doi.org\/10.1080\/07853890.2023.2180155","journal-title":"Annals of Medicine"},{"issue":"5","key":"10368_CR113","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.7150\/ijbs.107045","volume":"21","author":"P Hernandez-Camarero","year":"2025","unstructured":"Hernandez-Camarero, P., Toledo, B., Diaz-Ruano, A. B., Gonzalez-Titos, A., Garcia-Ortega, M. B., & Peran, M. (2025). What is the impact of endothelial-to-mesenchymal transition in solid tumours: A qualitative systematic review and quantitative meta-analysis. International Journal of Biological Sciences, 21(5), 2155\u20132178. https:\/\/doi.org\/10.7150\/ijbs.107045","journal-title":"International Journal of Biological Sciences"},{"key":"10368_CR114","doi-asserted-by":"publisher","first-page":"740827","DOI":"10.3389\/fcell.2021.740827","volume":"9","author":"JN Cheng","year":"2021","unstructured":"Cheng, J. N., Yuan, Y. X., Zhu, B., & Jia, Q. (2021). Myeloid-derived suppressor cells: A multifaceted accomplice in tumor progression. Front Cell Dev Biol, 9, 740827. https:\/\/doi.org\/10.3389\/fcell.2021.740827","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10368_CR115","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13045-024-01634-6","volume":"18","author":"A Glaviano","year":"2025","unstructured":"Glaviano, A., Lau, H. S., Carter, L. M., Lee, E. H. C., Lam, H. Y., Okina, E., et al. (2025). Harnessing the tumor microenvironment: Targeted cancer therapies through modulation of epithelial-mesenchymal transition. Journal of Hematology & Oncology, 18(1), 6. https:\/\/doi.org\/10.1186\/s13045-024-01634-6","journal-title":"Journal of Hematology & Oncology"},{"issue":"11","key":"10368_CR116","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1038\/s41591-024-03215-z","volume":"30","author":"J Klughammer","year":"2024","unstructured":"Klughammer, J., Abravanel, D. L., Segerstolpe, A., Blosser, T. R., Goltsev, Y., Cui, Y., et al. (2024). A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features. Nature Medicine, 30(11), 3236\u20133249. https:\/\/doi.org\/10.1038\/s41591-024-03215-z","journal-title":"Nature Medicine"},{"issue":"5","key":"10368_CR117","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/ng.3818","volume":"49","author":"H Li","year":"2017","unstructured":"Li, H., Courtois, E. T., Sengupta, D., Tan, Y., Chen, K. H., Goh, J. J. L., et al. (2017). Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors. Nature Genetics, 49(5), 708\u2013718. https:\/\/doi.org\/10.1038\/ng.3818","journal-title":"Nature Genetics"},{"issue":"1","key":"10368_CR118","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12943-023-01876-x","volume":"22","author":"C Ma","year":"2023","unstructured":"Ma, C., Yang, C., Peng, A., Sun, T., Ji, X., Mi, J., et al. (2023). Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment. Molecular Cancer, 22(1), 170. https:\/\/doi.org\/10.1186\/s12943-023-01876-x","journal-title":"Molecular Cancer"},{"issue":"1\u20132","key":"10368_CR119","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","volume":"148","author":"AD Rhim","year":"2012","unstructured":"Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., et al. (2012). EMT and dissemination precede pancreatic tumor formation. Cell, 148(1\u20132), 349\u2013361. https:\/\/doi.org\/10.1016\/j.cell.2011.11.025","journal-title":"Cell"},{"issue":"7634","key":"10368_CR120","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature20785","volume":"540","author":"H Hosseini","year":"2016","unstructured":"Hosseini, H., Obradovic, M. M. S., Hoffmann, M., Harper, K. L., Sosa, M. S., Werner-Klein, M., et al. (2016). Early dissemination seeds metastasis in breast cancer. Nature, 540(7634), 552\u2013558. https:\/\/doi.org\/10.1038\/nature20785","journal-title":"Nature"},{"issue":"12","key":"10368_CR121","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41568-019-0213-x","volume":"19","author":"ED Williams","year":"2019","unstructured":"Williams, E. D., Gao, D., Redfern, A., & Thompson, E. W. (2019). Controversies around epithelial-mesenchymal plasticity in cancer metastasis. Nature Reviews Cancer, 19(12), 716\u2013732. https:\/\/doi.org\/10.1038\/s41568-019-0213-x","journal-title":"Nature Reviews Cancer"},{"issue":"3","key":"10368_CR122","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/ncb3478","volume":"19","author":"A Labernadie","year":"2017","unstructured":"Labernadie, A., Kato, T., Brugues, A., Serra-Picamal, X., Derzsi, S., Arwert, E., et al. (2017). A mechanically active heterotypic E-cadherin\/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion. Nature Cell Biology, 19(3), 224\u2013237. https:\/\/doi.org\/10.1038\/ncb3478","journal-title":"Nature Cell Biology"},{"key":"10368_CR123","doi-asserted-by":"publisher","first-page":"15078","DOI":"10.1038\/ncomms15078","volume":"8","author":"J Konen","year":"2017","unstructured":"Konen, J., Summerbell, E., Dwivedi, B., Galior, K., Hou, Y., Rusnak, L., et al. (2017). Image-guided genomics of phenotypically heterogeneous populations reveals vascular signalling during symbiotic collective cancer invasion. Nature Communications, 8, 15078. https:\/\/doi.org\/10.1038\/ncomms15078","journal-title":"Nature Communications"},{"issue":"18","key":"10368_CR124","doi-asserted-by":"publisher","first-page":"5229","DOI":"10.1158\/0008-5472.CAN-18-0601","volume":"78","author":"EM Grasset","year":"2018","unstructured":"Grasset, E. M., Bertero, T., Bozec, A., Friard, J., Bourget, I., Pisano, S., et al. (2018). Matrix stiffening and EGFR cooperate to promote the collective invasion of cancer cells. Cancer Research, 78(18), 5229\u20135242. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0601","journal-title":"Cancer Research"},{"issue":"9","key":"10368_CR125","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/s41556-020-0552-6","volume":"22","author":"O Ilina","year":"2020","unstructured":"Ilina, O., Gritsenko, P. G., Syga, S., Lippoldt, J., La Porta, C. A. M., Chepizhko, O., et al. (2020). Cell-cell adhesion and 3D matrix confinement determine jamming transitions in breast cancer invasion. Nature Cell Biology, 22(9), 1103\u20131115. https:\/\/doi.org\/10.1038\/s41556-020-0552-6","journal-title":"Nature Cell Biology"},{"issue":"4","key":"10368_CR126","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cell.2018.12.038","volume":"176","author":"M Georgouli","year":"2019","unstructured":"Georgouli, M., Herraiz, C., Crosas-Molist, E., Fanshawe, B., Maiques, O., Perdrix, A., et al. (2019). Regional activation of myosin II in cancer cells drives tumor progression via a secretory cross-talk with the immune microenvironment. Cell, 176(4), 757-774 e723. https:\/\/doi.org\/10.1016\/j.cell.2018.12.038","journal-title":"Cell"},{"issue":"7","key":"10368_CR127","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.cmet.2021.04.002","volume":"33","author":"MR Zanotelli","year":"2021","unstructured":"Zanotelli, M. R., Zhang, J., & Reinhart-King, C. A. (2021). Mechanoresponsive metabolism in cancer cell migration and metastasis. Cell Metabolism, 33(7), 1307\u20131321. https:\/\/doi.org\/10.1016\/j.cmet.2021.04.002","journal-title":"Cell Metabolism"},{"issue":"20","key":"10368_CR128","doi-asserted-by":"publisher","first-page":"5230","DOI":"10.1016\/j.cell.2021.08.035","volume":"184","author":"GPF Nader","year":"2021","unstructured":"Nader, G. P. F., Aguera-Gonzalez, S., Routet, F., Gratia, M., Maurin, M., Cancila, V., et al. (2021). Compromised nuclear envelope integrity drives TREX1-dependent DNA damage and tumor cell invasion. Cell, 184(20), 5230-5246 e5222. https:\/\/doi.org\/10.1016\/j.cell.2021.08.035","journal-title":"Cell"},{"issue":"7","key":"10368_CR129","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1158\/2159-8290.CD-19-0015","volume":"9","author":"S Yuan","year":"2019","unstructured":"Yuan, S., Norgard, R. J., & Stanger, B. Z. (2019). Cellular plasticity in cancer. Cancer Discovery, 9(7), 837\u2013851. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0015","journal-title":"Cancer Discovery"},{"issue":"7","key":"10368_CR130","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","volume":"171","author":"SV Puram","year":"2017","unstructured":"Puram, S. V., Tirosh, I., Parikh, A. S., Patel, A. P., Yizhak, K., Gillespie, S., et al. (2017). Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell, 171(7), 1611-1624 e1624. https:\/\/doi.org\/10.1016\/j.cell.2017.10.044","journal-title":"Cell"},{"issue":"1","key":"10368_CR131","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1158\/2159-8290.CD-18-0065","volume":"9","author":"X Liu","year":"2019","unstructured":"Liu, X., Taftaf, R., Kawaguchi, M., Chang, Y. F., Chen, W., Entenberg, D., et al. (2019). Homophilic CD44 interactions mediate tumor cell aggregation and polyclonal metastasis in patient-derived breast cancer models. Cancer Discovery, 9(1), 96\u2013113. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-0065","journal-title":"Cancer Discovery"},{"issue":"1\u20132","key":"10368_CR132","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cell.2018.11.046","volume":"176","author":"S Gkountela","year":"2019","unstructured":"Gkountela, S., Castro-Giner, F., Szczerba, B. M., Vetter, M., Landin, J., Scherrer, R., et al. (2019). Circulating tumor cell clustering shapes DNA methylation to enable metastasis seeding. Cell, 176(1\u20132), 98-112 e114. https:\/\/doi.org\/10.1016\/j.cell.2018.11.046","journal-title":"Cell"},{"issue":"7","key":"10368_CR133","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s43018-020-0068-9","volume":"1","author":"HC Lo","year":"2020","unstructured":"Lo, H. C., Xu, Z., Kim, I. S., Pingel, B., Aguirre, S., Kodali, S., et al. (2020). Resistance to natural killer cell immunosurveillance confers a selective advantage to polyclonal metastasis. Nat Cancer, 1(7), 709\u2013722. https:\/\/doi.org\/10.1038\/s43018-020-0068-9","journal-title":"Nat Cancer"},{"issue":"7745","key":"10368_CR134","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-019-0915-y","volume":"566","author":"BM Szczerba","year":"2019","unstructured":"Szczerba, B. M., Castro-Giner, F., Vetter, M., Krol, I., Gkountela, S., Landin, J., et al. (2019). Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature, 566(7745), 553\u2013557. https:\/\/doi.org\/10.1038\/s41586-019-0915-y","journal-title":"Nature"},{"issue":"1","key":"10368_CR135","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12943-024-01984-2","volume":"23","author":"LM Rieckmann","year":"2024","unstructured":"Rieckmann, L. M., Spohn, M., Ruff, L., Agorku, D., Becker, L., Borchers, A., et al. (2024). Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cells. Molecular Cancer, 23(1), 93. https:\/\/doi.org\/10.1186\/s12943-024-01984-2","journal-title":"Molecular Cancer"},{"issue":"7774","key":"10368_CR136","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41586-019-1526-3","volume":"573","author":"V Padmanaban","year":"2019","unstructured":"Padmanaban, V., Krol, I., Suhail, Y., Szczerba, B. M., Aceto, N., Bader, J. S., et al. (2019). E-cadherin is required for metastasis in multiple models of breast cancer. Nature, 573(7774), 439\u2013444. https:\/\/doi.org\/10.1038\/s41586-019-1526-3","journal-title":"Nature"},{"issue":"5","key":"10368_CR137","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41556-019-0309-2","volume":"21","author":"M Esposito","year":"2019","unstructured":"Esposito, M., Mondal, N., Greco, T. M., Wei, Y., Spadazzi, C., Lin, S. C., et al. (2019). Bone vascular niche E-selectin induces mesenchymal-epithelial transition and Wnt activation in cancer cells to promote bone metastasis. Nature Cell Biology, 21(5), 627\u2013639. https:\/\/doi.org\/10.1038\/s41556-019-0309-2","journal-title":"Nature Cell Biology"},{"issue":"18","key":"10368_CR138","doi-asserted-by":"publisher","first-page":"10356","DOI":"10.1073\/pnas.171610498","volume":"98","author":"T Brabletz","year":"2001","unstructured":"Brabletz, T., Jung, A., Reu, S., Porzner, M., Hlubek, F., Kunz-Schughart, L. A., et al. (2001). Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proceedings of the National Academy of Sciences, 98(18), 10356\u201310361. https:\/\/doi.org\/10.1073\/pnas.171610498","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"656","key":"10368_CR139","doi-asserted-by":"publisher","first-page":"eabn7571","DOI":"10.1126\/scitranslmed.abn7571","volume":"14","author":"EM Grasset","year":"2022","unstructured":"Grasset, E. M., Dunworth, M., Sharma, G., Loth, M., Tandurella, J., Cimino-Mathews, A., et al. (2022). Triple-negative breast cancer metastasis involves complex epithelial-mesenchymal transition dynamics and requires vimentin. Science Translational Medicine, 14(656), eabn7571. https:\/\/doi.org\/10.1126\/scitranslmed.abn7571","journal-title":"Science Translational Medicine"},{"issue":"1","key":"10368_CR140","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41388-020-01518-2","volume":"40","author":"RK Nimmakayala","year":"2021","unstructured":"Nimmakayala, R. K., Leon, F., Rachagani, S., Rauth, S., Nallasamy, P., Marimuthu, S., et al. (2021). Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma. Oncogene, 40(1), 215\u2013231. https:\/\/doi.org\/10.1038\/s41388-020-01518-2","journal-title":"Oncogene"},{"issue":"7","key":"10368_CR141","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/carcin\/bgz191","volume":"41","author":"G Voss","year":"2020","unstructured":"Voss, G., Haflidadottir, B. S., Jaremo, H., Persson, M., Catela Ivkovic, T., Wikstrom, P., et al. (2020). Regulation of cell-cell adhesion in prostate cancer cells by microRNA-96 through upregulation of E-Cadherin and EpCAM. Carcinogenesis, 41(7), 865\u2013874. https:\/\/doi.org\/10.1093\/carcin\/bgz191","journal-title":"Carcinogenesis"},{"issue":"7658","key":"10368_CR142","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature22794","volume":"546","author":"SM Shaffer","year":"2017","unstructured":"Shaffer, S. M., Dunagin, M. C., Torborg, S. R., Torre, E. A., Emert, B., Krepler, C., et al. (2017). Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature, 546(7658), 431\u2013435. https:\/\/doi.org\/10.1038\/nature22794","journal-title":"Nature"},{"issue":"10","key":"10368_CR143","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1002\/ijc.32364","volume":"145","author":"A Steins","year":"2019","unstructured":"Steins, A., Ebbing, E. A., Creemers, A., van der Zalm, A. P., Jibodh, R. A., Waasdorp, C., et al. (2019). Chemoradiation induces epithelial-to-mesenchymal transition in esophageal adenocarcinoma. International Journal of Cancer, 145(10), 2792\u20132803. https:\/\/doi.org\/10.1002\/ijc.32364","journal-title":"International Journal of Cancer"},{"key":"10368_CR144","doi-asserted-by":"publisher","unstructured":"Shintani, Y., Okimura, A., Sato, K., Nakagiri, T., Kadota, Y., Inoue, M., et al. (2011). Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer. Ann Thorac Surg, 92(5), 1794\u20131804; discussion 1804. https:\/\/doi.org\/10.1016\/j.athoracsur.2011.07.032.","DOI":"10.1016\/j.athoracsur.2011.07.032"},{"issue":"3","key":"10368_CR145","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s43018-026-01130-5","volume":"7","author":"JX Yu","year":"2026","unstructured":"Yu, J. X., Suh, J. M., Popova, K. D., Garcia, K., Joshi, T., Culbertson, B., et al. (2026). The GENEVA platform models tumor mosaicism to reveal variations of responses to KRAS inhibitors and identify improved drug combinations. Nature Cancer, 7(3), 522\u2013537. https:\/\/doi.org\/10.1038\/s43018-026-01130-5","journal-title":"Nature Cancer"},{"issue":"1","key":"10368_CR146","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccell.2025.10.010","volume":"44","author":"Y Zhang","year":"2026","unstructured":"Zhang, Y., Chen, J., She, Y., Fang, Z., Zhang, Y., Ruan, D., et al. (2026). Paneth-like transition drives resistance to dual targeting of KRAS and EGFR in colorectal cancer. Cancer Cell, 44(1), 77-93 e78. https:\/\/doi.org\/10.1016\/j.ccell.2025.10.010","journal-title":"Cancer Cell"},{"issue":"1","key":"10368_CR147","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41573-019-0044-1","volume":"19","author":"S Boumahdi","year":"2020","unstructured":"Boumahdi, S., & de Sauvage, F. J. (2020). The great escape: Tumour cell plasticity in resistance to targeted therapy. Nature Reviews Drug Discovery, 19(1), 39\u201356. https:\/\/doi.org\/10.1038\/s41573-019-0044-1","journal-title":"Nature Reviews Drug Discovery"},{"issue":"448","key":"10368_CR148","doi-asserted-by":"publisher","first-page":"ra97","DOI":"10.1126\/scisignal.aaf8175","volume":"9","author":"J Antony","year":"2016","unstructured":"Antony, J., Tan, T. Z., Kelly, Z., Low, J., Choolani, M., Recchi, C., et al. (2016). The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer. Science Signaling, 9(448), ra97. https:\/\/doi.org\/10.1126\/scisignal.aaf8175","journal-title":"Science Signaling"},{"issue":"7","key":"10368_CR149","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/emmm.201201823","volume":"5","author":"TZ Tan","year":"2013","unstructured":"Tan, T. Z., Miow, Q. H., Huang, R. Y., Wong, M. K., Ye, J., Lau, J. A., et al. (2013). Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer. EMBO Molecular Medicine, 5(7), 1051\u20131066. https:\/\/doi.org\/10.1002\/emmm.201201823","journal-title":"EMBO Molecular Medicine"},{"issue":"3","key":"10368_CR150","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.eururo.2018.08.027","volume":"75","author":"TZ Tan","year":"2019","unstructured":"Tan, T. Z., Rouanne, M., Tan, K. T., Huang, R. Y., & Thiery, J. P. (2019). Molecular subtypes of urothelial bladder cancer: Results from a meta-cohort analysis of 2411 tumors. European Urology, 75(3), 423\u2013432. https:\/\/doi.org\/10.1016\/j.eururo.2018.08.027","journal-title":"European Urology"},{"issue":"1","key":"10368_CR151","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13058-020-01304-8","volume":"22","author":"A Emad","year":"2020","unstructured":"Emad, A., Ray, T., Jensen, T. W., Parat, M., Natrajan, R., Sinha, S., et al. (2020). Superior breast cancer metastasis risk stratification using an epithelial-mesenchymal-amoeboid transition gene signature. Breast Cancer Research, 22(1), 74. https:\/\/doi.org\/10.1186\/s13058-020-01304-8","journal-title":"Breast Cancer Research"},{"key":"10368_CR152","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.2147\/OTT.S256818","volume":"13","author":"LY Wei","year":"2020","unstructured":"Wei, L. Y., Zhang, X. J., Wang, L., Hu, L. N., Zhang, X. D., Li, L., et al. (2020). A six-epithelial-mesenchymal transition gene signature may predict metastasis of triple-negative breast cancer. Oncotargets and Therapy, 13, 6497\u20136509. https:\/\/doi.org\/10.2147\/OTT.S256818","journal-title":"Oncotargets and Therapy"},{"issue":"4","key":"10368_CR153","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s13058-014-0407-9","volume":"16","author":"Q Cheng","year":"2014","unstructured":"Cheng, Q., Chang, J. T., Gwin, W. R., Zhu, J., Ambs, S., Geradts, J., et al. (2014). A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype. Breast Cancer Research, 16(4), 407. https:\/\/doi.org\/10.1186\/s13058-014-0407-9","journal-title":"Breast Cancer Research"},{"issue":"10","key":"10368_CR154","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41571-025-01058-2","volume":"22","author":"EW Thompson","year":"2025","unstructured":"Thompson, E. W., Redfern, A. D., Brabletz, S., Berx, G., Agarwal, V., Ganesh, K., et al. (2025). EMT and cancer: What clinicians should know. Nature Reviews Clinical Oncology, 22(10), 711\u2013733. https:\/\/doi.org\/10.1038\/s41571-025-01058-2","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"2","key":"10368_CR155","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ccell.2020.06.012","volume":"38","author":"ND Marjanovic","year":"2020","unstructured":"Marjanovic, N. D., Hofree, M., Chan, J. E., Canner, D., Wu, K., Trakala, M., et al. (2020). Emergence of a high-plasticity cell state during lung cancer evolution. Cancer Cell, 38(2), 229-246 e213. https:\/\/doi.org\/10.1016\/j.ccell.2020.06.012","journal-title":"Cancer Cell"},{"issue":"7842","key":"10368_CR156","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41586-020-03046-1","volume":"589","author":"I Pastushenko","year":"2021","unstructured":"Pastushenko, I., Mauri, F., Song, Y., de Cock, F., Meeusen, B., Swedlund, B., et al. (2021). Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis. Nature, 589(7842), 448\u2013455. https:\/\/doi.org\/10.1038\/s41586-020-03046-1","journal-title":"Nature"},{"issue":"11","key":"10368_CR157","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s43018-024-00839-5","volume":"5","author":"KK Youssef","year":"2024","unstructured":"Youssef, K. K., Narwade, N., Arcas, A., Marquez-Galera, A., Jimenez-Castano, R., Lopez-Blau, C., et al. (2024). Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations. Nature Cancer, 5(11), 1660\u20131680. https:\/\/doi.org\/10.1038\/s43018-024-00839-5","journal-title":"Nature Cancer"},{"issue":"5","key":"10368_CR158","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1053\/j.gastro.2020.07.046","volume":"159","author":"A Tiwari","year":"2020","unstructured":"Tiwari, A., Tashiro, K., Dixit, A., Soni, A., Vogel, K., Hall, B., et al. (2020). Loss of HIF1A from pancreatic cancer cells increases expression of PPP1R1B and degradation of p53 to promote invasion and metastasis. Gastroenterology, 159(5), 1882-1897 e1885. https:\/\/doi.org\/10.1053\/j.gastro.2020.07.046","journal-title":"Gastroenterology"},{"issue":"6","key":"10368_CR159","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ccr.2012.10.012","volume":"22","author":"OH Ocana","year":"2012","unstructured":"Ocana, O. H., Corcoles, R., Fabra, A., Moreno-Bueno, G., Acloque, H., Vega, S., et al. (2012). Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell, 22(6), 709\u2013724. https:\/\/doi.org\/10.1016\/j.ccr.2012.10.012","journal-title":"Cancer Cell"},{"issue":"10","key":"10368_CR160","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1038\/s41592-025-02824-x","volume":"22","author":"C Yapp","year":"2025","unstructured":"Yapp, C., Nirmal, A. J., Zhou, F., Wong, A. Y. H., Tefft, J. B., Lu, Y. D., et al. (2025). Highly multiplexed 3D profiling of cell states and immune niches in human tumors. Nature Methods, 22(10), 2180\u20132193. https:\/\/doi.org\/10.1038\/s41592-025-02824-x","journal-title":"Nature Methods"},{"issue":"1","key":"10368_CR161","doi-asserted-by":"publisher","first-page":"9886","DOI":"10.1038\/s41467-024-54182-5","volume":"15","author":"M Pizurica","year":"2024","unstructured":"Pizurica, M., Zheng, Y., Carrillo-Perez, F., Noor, H., Yao, W., Wohlfart, C., et al. (2024). Digital profiling of gene expression from histology images with linearized attention. Nature Communications, 15(1), 9886. https:\/\/doi.org\/10.1038\/s41467-024-54182-5","journal-title":"Nature Communications"},{"issue":"1","key":"10368_CR162","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/s41467-025-67965-1","volume":"17","author":"L Chadoutaud","year":"2026","unstructured":"Chadoutaud, L., Lerousseau, M., Herrero-Saboya, D., Ostermaier, J., Fontugne, J., Barillot, E., et al. (2026). sCellST predicts single-cell gene expression from H& E images. Nature Communications, 17(1), 1194. https:\/\/doi.org\/10.1038\/s41467-025-67965-1","journal-title":"Nature Communications"},{"key":"10368_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216769","volume":"588","author":"Z Ye","year":"2024","unstructured":"Ye, Z., Li, Q., Hu, Y., Hu, H., Xu, J., Guo, M., et al. (2024). The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes. Cancer Letters, 588, Article 216769. https:\/\/doi.org\/10.1016\/j.canlet.2024.216769","journal-title":"Cancer Letters"},{"issue":"1","key":"10368_CR164","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12943-025-02343-5","volume":"24","author":"SY Hwang","year":"2025","unstructured":"Hwang, S. Y., Seo, Y., Park, S., Kim, S. A., Moon, I., Liu, Y., et al. (2025). Targeting the HER2-ELF3-KRAS axis: A novel therapeutic strategy for KRAS(G13D) colorectal cancer. Molecular Cancer, 24(1), 139. https:\/\/doi.org\/10.1186\/s12943-025-02343-5","journal-title":"Molecular Cancer"},{"issue":"12","key":"10368_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100870","volume":"23","author":"K Kume","year":"2024","unstructured":"Kume, K., Iida, M., Iwaya, T., Yashima-Abo, A., Koizumi, Y., Endo, A., et al. (2024). Targeted dynamic phospho-proteogenomic analysis of gastric cancer cells suggests host immunity provides survival benefit. Molecular & Cellular Proteomics, 23(12), Article 100870. https:\/\/doi.org\/10.1016\/j.mcpro.2024.100870","journal-title":"Molecular & Cellular Proteomics"},{"issue":"1","key":"10368_CR166","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00280-025-04783-8","volume":"95","author":"M Miyake","year":"2025","unstructured":"Miyake, M., Owari, T., Iida, K., Onishi, S., Nishimura, N., Fujii, T., et al. (2025). Clinical relevance of Nectin-4 downregulation and biological changes caused by cytotoxic chemotherapy in bladder cancer. Cancer Chemotherapy and Pharmacology, 95(1), 62. https:\/\/doi.org\/10.1007\/s00280-025-04783-8","journal-title":"Cancer Chemotherapy and Pharmacology"},{"issue":"6119","key":"10368_CR167","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1126\/science.1228522","volume":"339","author":"M Yu","year":"2013","unstructured":"Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., et al. (2013). Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science, 339(6119), 580\u2013584. https:\/\/doi.org\/10.1126\/science.1228522","journal-title":"Science"},{"issue":"2","key":"10368_CR168","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3892\/or.2020.7629","volume":"44","author":"DD Shi","year":"2020","unstructured":"Shi, D. D., Yang, C. G., Han, S., Wang, S. Y., & Xiong, B. (2020). Dynamic evaluation of mesenchymal circulating tumor cells in patients with colorectal cancer: Clinical associations and prognostic value. Oncology Reports, 44(2), 757\u2013767. https:\/\/doi.org\/10.3892\/or.2020.7629","journal-title":"Oncology Reports"},{"issue":"5","key":"10368_CR169","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1097\/JS9.0000000000000249","volume":"109","author":"X Guo","year":"2023","unstructured":"Guo, X., Gao, Y., Song, Q., Wei, J., Wu, J., Dong, J., et al. (2023). Early assessment of circulating exosomal lncRNA-GC1 for monitoring neoadjuvant chemotherapy response in gastric cancer. International Journal of Surgery, 109(5), 1094\u20131104. https:\/\/doi.org\/10.1097\/JS9.0000000000000249","journal-title":"International Journal of Surgery"},{"issue":"11","key":"10368_CR170","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.jtho.2024.07.008","volume":"19","author":"JE Gray","year":"2024","unstructured":"Gray, J. E., Markovets, A., Reungwetwattana, T., Majem, M., Nogami, N., Peled, N., et al. (2024). Longitudinal analyses of circulating tumor DNA for the detection of EGFR mutation-positive advanced NSCLC progression during treatment: Data from FLAURA and AURA3. Journal of Thoracic Oncology, 19(11), 1525\u20131538. https:\/\/doi.org\/10.1016\/j.jtho.2024.07.008","journal-title":"Journal of Thoracic Oncology"},{"issue":"16","key":"10368_CR171","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1158\/0008-5472.CAN-22-3645","volume":"83","author":"D Rohila","year":"2023","unstructured":"Rohila, D., Park, I. H., Pham, T. V., Weitz, J., Hurtado de Mendoza, T., Madheswaran, S., et al. (2023). Syk inhibition reprograms tumor-associated macrophages and overcomes gemcitabine-induced immunosuppression in pancreatic ductal adenocarcinoma. Cancer Research, 83(16), 2675\u20132689. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-3645","journal-title":"Cancer Research"},{"issue":"30","key":"10368_CR172","doi-asserted-by":"publisher","first-page":"eadw2937","DOI":"10.1126\/sciadv.adw2937","volume":"11","author":"W Xu","year":"2025","unstructured":"Xu, W., Li, S., Shan, X., Wang, Q., Chen, X., Wu, S., et al. (2025). Targeting tumor-associated CCR2(+) macrophages to inhibit pancreatic cancer recurrence following irreversible electroporation. Science Advances, 11(30), eadw2937. https:\/\/doi.org\/10.1126\/sciadv.adw2937","journal-title":"Science Advances"},{"issue":"1","key":"10368_CR173","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccell.2018.12.002","volume":"35","author":"D Ishay-Ronen","year":"2019","unstructured":"Ishay-Ronen, D., Diepenbruck, M., Kalathur, R. K. R., Sugiyama, N., Tiede, S., Ivanek, R., et al. (2019). Gain fat-lose metastasis: Converting invasive breast cancer cells into adipocytes inhibits cancer metastasis. Cancer Cell, 35(1), 17-32 e16. https:\/\/doi.org\/10.1016\/j.ccell.2018.12.002","journal-title":"Cancer Cell"},{"key":"10368_CR174","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145106","author":"HH Chung","year":"2020","unstructured":"Chung, H. H., Lee, C. T., Hu, J. M., Chou, Y. C., Lin, Y. W., & Shih, Y. L. (2020). NKX6.1 represses tumorigenesis, metastasis, and chemoresistance in colorectal cancer. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms21145106","journal-title":"International Journal of Molecular Sciences"},{"issue":"6776","key":"10368_CR175","doi-asserted-by":"publisher","DOI":"10.1126\/science.adi8577","volume":"390","author":"B DeMeo","year":"2025","unstructured":"DeMeo, B., Nesbitt, C., Miller, S. A., Burkhardt, D. B., Lipchina, I., Fu, D., et al. (2025). Active learning framework leveraging transcriptomics identifies modulators of disease phenotypes. Science, 390(6776), Article eadi8577. https:\/\/doi.org\/10.1126\/science.adi8577","journal-title":"Science"},{"key":"10368_CR176","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-026-10436-4","author":"G Roth","year":"2026","unstructured":"Roth, G., Artru, P., Bouche, O., Williet, N., Ghelfi, J., Turpin, A., et al. (2026). Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer. Nature. https:\/\/doi.org\/10.1038\/s41586-026-10436-4","journal-title":"Nature"},{"issue":"11","key":"10368_CR177","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1158\/1078-0432.CCR-14-3252","volume":"21","author":"NF Dybdal-Hargreaves","year":"2015","unstructured":"Dybdal-Hargreaves, N. F., Risinger, A. L., & Mooberry, S. L. (2015). Eribulin mesylate: Mechanism of action of a unique microtubule-targeting agent. Clinical Cancer Research, 21(11), 2445\u20132452. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-3252","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"10368_CR178","doi-asserted-by":"publisher","first-page":"92558","DOI":"10.5493\/wjem.v14.i2.92558","volume":"14","author":"O Oey","year":"2024","unstructured":"Oey, O., Wijaya, W., & Redfern, A. (2024). Eribulin in breast cancer: Current insights and therapeutic perspectives. World J Exp Med, 14(2), 92558. https:\/\/doi.org\/10.5493\/wjem.v14.i2.92558","journal-title":"World J Exp Med"},{"key":"10368_CR179","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123735","author":"H Polioudaki","year":"2020","unstructured":"Polioudaki, H., Mala, A., Gkimprixi, E., Papadaki, M. A., Chantziou, A., Tzardi, M., et al. (2020). Epithelial\/mesenchymal characteristics and PD-L1 co-expression in CTCs of metastatic breast cancer patients treated with eribulin: Correlation with clinical outcome. Cancers. https:\/\/doi.org\/10.3390\/cancers12123735","journal-title":"Cancers"},{"issue":"14","key":"10368_CR180","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.2217\/fon-2018-0936","volume":"15","author":"J O'Shaughnessy","year":"2019","unstructured":"O\u2019Shaughnessy, J., Kaklamani, V., & Kalinsky, K. (2019). Perspectives on the mechanism of action and clinical application of eribulin for metastatic breast cancer. Future Oncology, 15(14), 1641\u20131653. https:\/\/doi.org\/10.2217\/fon-2018-0936","journal-title":"Future Oncology"},{"issue":"2","key":"10368_CR181","doi-asserted-by":"publisher","first-page":"917","DOI":"10.21873\/invivo.11858","volume":"34","author":"T Fujii","year":"2020","unstructured":"Fujii, T., Tokuda, S., Nakazawa, Y., Kurozumi, S., Obayashi, S., Yajima, R., et al. (2020). Eribulin suppresses new metastases in patients with metastatic breast cancer. In Vivo, 34(2), 917\u2013921. https:\/\/doi.org\/10.21873\/invivo.11858","journal-title":"In Vivo"},{"issue":"8","key":"10368_CR182","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.3390\/md13085016","volume":"13","author":"U Swami","year":"2015","unstructured":"Swami, U., Shah, U., & Goel, S. (2015). Eribulin in cancer treatment. Marine Drugs, 13(8), 5016\u20135058. https:\/\/doi.org\/10.3390\/md13085016","journal-title":"Marine Drugs"},{"key":"10368_CR183","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2147\/BCTT.S231298","volume":"13","author":"P Yuan","year":"2021","unstructured":"Yuan, P., & Xu, B. (2021). Clinical utility of eribulin mesylate in the treatment of breast cancer: A Chinese perspective. Breast Cancer (Dove Medical Press), 13, 135\u2013150. https:\/\/doi.org\/10.2147\/BCTT.S231298","journal-title":"Breast Cancer (Dove Medical Press)"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10368-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-026-10368-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10368-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T06:19:51Z","timestamp":1787379591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-026-10368-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":183,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["10368"],"URL":"https:\/\/doi.org\/10.1007\/s10555-026-10368-5","relation":{},"ISSN":["1573-7233"],"issn-type":[{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"assertion":[{"value":"15 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"\u00a0J.P.T. is a shareholder and chairman of Biocheetah Pte Ltd, Singapore. C.X.Z. is a full-time employee of AstraZeneca and shareholder of Biosyngen Pte Ltd. All other authors declare that they have no competing financial interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"63"}}